BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 16847340)

  • 1. Proteasomal inhibition attenuates transcriptional activity of hypoxia-inducible factor 1 (HIF-1) via specific effect on the HIF-1alpha C-terminal activation domain.
    Kaluz S; Kaluzová M; Stanbridge EJ
    Mol Cell Biol; 2006 Aug; 26(15):5895-907. PubMed ID: 16847340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of the hypoxia-inducible factor-1 response in cervical carcinoma xenografts by proteasome inhibitors.
    Birle DC; Hedley DW
    Cancer Res; 2007 Feb; 67(4):1735-43. PubMed ID: 17308115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of hypoxia-induced transcription in normoxia.
    Hägg M; Wennström S
    Exp Cell Res; 2005 May; 306(1):180-91. PubMed ID: 15878343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CITED2 mediates the paradoxical responses of HIF-1alpha to proteasome inhibition.
    Shin DH; Li SH; Chun YS; Huang LE; Kim MS; Park JW
    Oncogene; 2008 Mar; 27(13):1939-44. PubMed ID: 17906695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin and doxorubicin repress Vascular Endothelial Growth Factor expression and differentially down-regulate Hypoxia-inducible Factor I activity in human ovarian cancer cells.
    Duyndam MC; van Berkel MP; Dorsman JC; Rockx DA; Pinedo HM; Boven E
    Biochem Pharmacol; 2007 Jul; 74(2):191-201. PubMed ID: 17498666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of bortezomib on VEGF gene expression of endothelial cell line HMEC-1 and its possible mechanisms].
    Xue LX; Jiang M; Xie LQ; Ruan CG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):744-8. PubMed ID: 20561442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA interference targeting hypoxia-inducible factor 1α via a novel multifunctional surfactant attenuates glioma growth in an intracranial mouse model.
    Gillespie DL; Aguirre MT; Ravichandran S; Leishman LL; Berrondo C; Gamboa JT; Wang L; King R; Wang X; Tan M; Malamas A; Lu ZR; Jensen RL
    J Neurosurg; 2015 Feb; 122(2):331-41. PubMed ID: 25423275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA damage is a prerequisite for p53-mediated proteasomal degradation of HIF-1alpha in hypoxic cells and downregulation of the hypoxia marker carbonic anhydrase IX.
    Kaluzová M; Kaluz S; Lerman MI; Stanbridge EJ
    Mol Cell Biol; 2004 Jul; 24(13):5757-66. PubMed ID: 15199132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complex regulation of the transactivation function of hypoxia-inducible factor-1 alpha by direct interaction with two distinct domains of the CREB-binding protein/p300.
    Ruas JL; Berchner-Pfannschmidt U; Malik S; Gradin K; Fandrey J; Roeder RG; Pereira T; Poellinger L
    J Biol Chem; 2010 Jan; 285(4):2601-9. PubMed ID: 19880525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p300 relieves p53-evoked transcriptional repression of hypoxia-inducible factor-1 (HIF-1).
    Schmid T; Zhou J; Köhl R; Brüne B
    Biochem J; 2004 May; 380(Pt 1):289-95. PubMed ID: 14992692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bortezomib inhibits tumor adaptation to hypoxia by stimulating the FIH-mediated repression of hypoxia-inducible factor-1.
    Shin DH; Chun YS; Lee DS; Huang LE; Park JW
    Blood; 2008 Mar; 111(6):3131-6. PubMed ID: 18174379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Menadione and ethacrynic acid inhibit the hypoxia-inducible factor (HIF) pathway by disrupting HIF-1α interaction with p300.
    Na YR; Han KC; Park H; Yang EG
    Biochem Biophys Res Commun; 2013 May; 434(4):879-84. PubMed ID: 23618863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
    Chen MC; Lee CF; Huang WH; Chou TC
    Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression patterns of the hypoxia-related genes osteopontin, CA9, erythropoietin, VEGF and HIF-1alpha in human glioma in vitro and in vivo.
    Said HM; Hagemann C; Staab A; Stojic J; Kühnel S; Vince GH; Flentje M; Roosen K; Vordermark D
    Radiother Oncol; 2007 Jun; 83(3):398-405. PubMed ID: 17524506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Src induces expression of carbonic anhydrase IX via hypoxia-inducible factor 1.
    Takacova M; Holotnakova T; Barathova M; Pastorekova S; Kopacek J; Pastorek J
    Oncol Rep; 2010 Mar; 23(3):869-74. PubMed ID: 20127031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lowered oxygen tension induces expression of the hypoxia marker MN/carbonic anhydrase IX in the absence of hypoxia-inducible factor 1 alpha stabilization: a role for phosphatidylinositol 3'-kinase.
    Kaluz S; Kaluzová M; Chrastina A; Olive PL; Pastoreková S; Pastorek J; Lerman MI; Stanbridge EJ
    Cancer Res; 2002 Aug; 62(15):4469-77. PubMed ID: 12154057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.
    Hui EP; Chan AT; Pezzella F; Turley H; To KF; Poon TC; Zee B; Mo F; Teo PM; Huang DP; Gatter KC; Johnson PJ; Harris AL
    Clin Cancer Res; 2002 Aug; 8(8):2595-604. PubMed ID: 12171890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FBXL5 modulates HIF-1α transcriptional activity by degradation of CITED2.
    Machado-Oliveira G; Guerreiro E; Matias AC; Facucho-Oliveira J; Pacheco-Leyva I; Bragança J
    Arch Biochem Biophys; 2015 Jun; 576():61-72. PubMed ID: 25956243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteasome-dependent regulation of signal transduction in retinal pigment epithelial cells.
    Fernandes AF; Guo W; Zhang X; Gallagher M; Ivan M; Taylor A; Pereira P; Shang F
    Exp Eye Res; 2006 Dec; 83(6):1472-81. PubMed ID: 17027001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia-inducible transcription factor-1 alpha determines sensitivity of endothelial cells to the proteosome inhibitor bortezomib.
    Veschini L; Belloni D; Foglieni C; Cangi MG; Ferrarini M; Caligaris-Cappio F; Ferrero E
    Blood; 2007 Mar; 109(6):2565-70. PubMed ID: 17110461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.